The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2011Implementation of PD GWAS meta-analysis results on the PDGene database
Objective/Rationale:
The goal of this proposal is to analyze all available Parkinson’s disease (PD) genomewide association study (GWAS) datasets so that we can identify gene variants associated with... -
MJFF Research Grant, 2011Axonopathy induced by overexpression of human -synuclein in the rat nigrostriatal dopamine system
Objective/Rationale:
Observations made in brains from patients with Parkinson’s disease indicate that the disease may start at the level of the axons and that loss of the affected neurons occur later... -
Rapid Response Innovation Awards, 2011Blood-Brain Barrier Modification Using Heterotopic Nasal Mucosal Grafting for Enhanced Symptoms & Side Effects and Macromolecular Disease Modifying Drug Delivery in Parkinson's Disease
Objective/Rationale:
One of the most significant problems in the treatment of Parkinson’s disease is the inability to provide continuous and high molecular weight drug delivery to the central nervous... -
LEAPS, 2011Supplement to 'Discovery of mGluR4 Potentiators for Symptoms & Side Effects and Disease-Modifying Treatment of PD'
Promising Outcomes of Original Grant:
Activation or potentiation of metabotropic glutamate receptor 4 (mGluR4) is a promising new strategy for both Symptoms & Side Effects and disease-modifying... -
Rapid Response Innovation Awards, 2011A New Strategy to Ameliorate Chemically-induced Parkinson-like Symptoms by Engaging the Spinal Locomotor Circuitry with Epidural Stimulation
Objective/Rationale:
Our objective is to determine if we can change the level of excitability of the spinal cord circuitry that controls posture and locomotion so that the sensory information derived... -
Research Grant, 2011Effect of Novel Neuronal Nicotinic Receptor Compounds on Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
Promising Outcomes of Original Grant:
The aim of the original grant was to identify compounds specifically targeting one or more neuronal nicotinic receptors (NNRs) in the central nervous system for...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.